Sun Pharma: Sun’s shining bright in India, rising across the world, too
The company has declared an interim dividend of ₹8.5 per share compared to ₹7.5 per share of interim dividend declared last fiscal year. Synopsis The revenues for the quarter grew nearly 10% while the net profit rose 16.5%. Both the domestic and US markets reported double-digit growth in revenues. The operating margin (Ebitda margin) rose … Read more
:quality(85):upscale()/2024/05/01/754/n/1922153/e51d6c816632769dd94a06.86103662_.png)
